Dawson James downgraded Bluejay Diagnostics to Neutral from Buy with no price target. Bluejay recently announced a 1-for-20 reverse stock split, notes the firm, which expects it will take “some time” for the company to rebuild its shareholder base as the company works to bring its IL-6 Point of Care test to the market.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BJDX:
